ArticleiScience2025

Development of the FGFR4-ADC bearing the ferroptosis inducer sulfasalazine for hepatocellular carcinoma.

Ying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.